INGALLS & SNYDER LLC Supernus Pharmaceuticals, Inc. Transaction History

INGALLS & SNYDER LLC portfolio value:

$1.36M
portfolio value

INGALLS & SNYDER LLC quarter portfolio value change:

+17.05%
quarter

Supernus Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 198K $33.85 40.18K
Q2 2022 share 0.00% 0 shares -137K $28.92 40.18K
Q1 2022 share 0.00% 0 shares 127K $32.32 40.18K
Q4 2021 share Decrease -42.58% -29.8K shares -695K $30.03 40.18K
Q3 2021 share Decrease -3.18% -2.3K shares -359K $26.67 69.98K
Q2 2021 share 0.00% 0 shares 334K $30.79 72.28K
Q1 2021 share 0.00% 0 shares 73K $26.18 72.28K
Q4 2020 share Increase +1.26% 900 shares 331K $25.16 72.28K
Q3 2020 share Increase +0.28% 200 shares -203K $20.84 71.38K
Q2 2020 share Increase +0.71% 500 shares 419K $23.75 71.18K
Q1 2020 share 0.00% 0 shares -405K $17.99 70.68K
Q4 2019 share Decrease -59.58% -104.2K shares -3.12M $23.72 70.68K
Q3 2019 share Increase +5.94% 9.8K shares -657K $27.48 174.88K
Q2 2019 share Decrease -3.22% -5.5K shares -514K $33.09 165.08K
Q1 2019 share Decrease -0.29% -500 shares 293K $35.04 170.58K
Q4 2018 share Decrease -0.06% -100 shares -2.93M $33.22 171.08K
Q3 2018 share 0.00% 0 shares -1.62M $50.35 171.18K
Q2 2018 share Decrease -1.35% -2.34K shares 2.29M $59.85 171.18K
Q1 2018 share Decrease -1.14% -2K shares 953K $45.8 173.53K
Q4 2017 share Decrease -0.06% -100 shares -30K $39.85 175.53K
Q3 2017 share 0.00% 0 shares -545K $40 175.63K
Q2 2017 share Decrease -2.77% -5K shares 1.91M $43.1 175.63K
Q1 2017 share Decrease -5.25% -10K shares 840K $31.3 180.63K
Q4 2016 share Decrease -1.04% -2K shares 50K $25.25 190.63K
Q3 2016 share 0.00% 0 shares 840K $24.73 192.63K
Q2 2016 share Increase 0.00% 192.63K shares 3.92M $20.37 192.63K